Aspect AI

Aspect is a biotechnology company that develops biological foundation models to revolutionize the drug discovery process. By combining generative artificial intelligence with high-throughput experimental biology, the company builds predictive models of cellular states and drug responses. Aspect's platform is designed to simulate complex biological interactions, allowing researchers to identify and optimize therapeutic candidates with unprecedented speed and accuracy. Founded by a team of AI experts from DeepMind and Google, the company aims to shift drug development from a stochastic process to a predictable engineering discipline. Aspect is currently focused on advancing its internal discovery programs while expanding its platform's capabilities across various therapeutic areas.